Shamaki GR, Soji-Ayoade D, Adedokun SD, Kesiena O, Favour M, Bolaji O, Ezeh EO, Okoh N, Sadiq AA, Baldawi H, Davis A, Bob-Manuel T
Abstract
Venous vascular diseases are an important clinical entity estimated to affect several million peo-ple worldwide. Deep vein thrombosis (DVT) is a com-mon venous disease with a population variable prevalence of 122 to 160 persons per 100,000 per year, whereas pulmonary embolism (PE) affects up to 60 to 70 per 100 000 and carries much higher mortal-ity. Chronic venous diseases, which cause symptoms like leg swelling, heaviness, pain, and discomfort, are most prevalent in the elderly and significantly impact their quality of life. Some estimate that chronic vascu-lar diseases account for up to 2% of healthcare budg-ets in Western countries. Treating venous vascular disease includes using systemic anticoagulation and interventional therapies in some patient subsets. In this comprehensive review, we discuss endovascu-lar treatment modalities in the management of venous vascular diseases. (Curr Probl Cardiol 2023;48:101534.)
